These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 20531002)

  • 1. Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival.
    Ercolani G; Vetrone G; Grazi GL; Aramaki O; Cescon M; Ravaioli M; Serra C; Brandi G; Pinna AD
    Ann Surg; 2010 Jul; 252(1):107-14. PubMed ID: 20531002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
    Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
    Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients.
    Yedibela S; Demir R; Zhang W; Meyer T; Hohenberger W; Schönleben F
    Ann Surg Oncol; 2009 Feb; 16(2):404-12. PubMed ID: 19037702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients.
    Rea DJ; Munoz-Juarez M; Farnell MB; Donohue JH; Que FG; Crownhart B; Larson D; Nagorney DM
    Arch Surg; 2004 May; 139(5):514-23; discussion 523-5. PubMed ID: 15136352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma.
    Tamandl D; Herberger B; Gruenberger B; Puhalla H; Klinger M; Gruenberger T
    Ann Surg Oncol; 2008 Oct; 15(10):2787-94. PubMed ID: 18685896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.
    Urahashi T; Yamamoto M; Ohtsubo T; Katsuragawa H; Katagiri S; Takasaki K
    Hepatogastroenterology; 2007 Mar; 54(74):346-9. PubMed ID: 17523271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases.
    Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T; Ojima H
    J Surg Oncol; 2007 Aug; 96(2):160-5. PubMed ID: 17443744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.
    Choi SB; Kim KS; Choi JY; Park SW; Choi JS; Lee WJ; Chung JB
    Ann Surg Oncol; 2009 Nov; 16(11):3048-56. PubMed ID: 19626372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival analysis of intrahepatic cholangiocarcinoma after resection.
    Cho SY; Park SJ; Kim SH; Han SS; Kim YK; Lee KW; Lee SA; Hong EK; Lee WJ; Woo SM
    Ann Surg Oncol; 2010 Jul; 17(7):1823-30. PubMed ID: 20165987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma.
    Li SQ; Liang LJ; Hua YP; Peng BG; He Q; Lu MD; Chen D
    Chin Med J (Engl); 2009 Oct; 122(19):2286-91. PubMed ID: 20079127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study.
    Wiedmann M; Caca K; Berr F; Schiefke I; Tannapfel A; Wittekind C; Mössner J; Hauss J; Witzigmann H
    Cancer; 2003 Jun; 97(11):2783-90. PubMed ID: 12767091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective analysis of histopathologic prognostic factors after hepatectomy for intrahepatic cholangiocarcinoma.
    Jiang BG; Sun LL; Yu WL; Tang ZH; Zong M; Zhang YJ
    Cancer J; 2009; 15(3):257-61. PubMed ID: 19556914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus.
    Sano T; Shimada K; Sakamoto Y; Ojima H; Esaki M; Kosuge T
    Ann Surg Oncol; 2008 Feb; 15(2):590-9. PubMed ID: 18057991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Our experiences in surgical treatment for hilar cholangiocarcinoma.
    Maeno H; Ono T; Yamanoi A; Nagasue N
    Hepatogastroenterology; 2007; 54(75):669-73. PubMed ID: 17591038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What prognostic factors are important for resected intrahepatic cholangiocarcinoma?
    Paik KY; Jung JC; Heo JS; Choi SH; Choi DW; Kim YI
    J Gastroenterol Hepatol; 2008 May; 23(5):766-70. PubMed ID: 17868336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma.
    Wakai T; Shirai Y; Moroda T; Yokoyama N; Hatakeyama K
    Cancer; 2005 Mar; 103(6):1210-6. PubMed ID: 15685618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing trends in surgical outcomes after major hepatobiliary resection for hilar cholangiocarcinoma: a single-center experience over 25 years.
    Sano T; Shimada K; Sakamoto Y; Esaki M; Kosuge T
    J Hepatobiliary Pancreat Surg; 2007; 14(5):455-62. PubMed ID: 17909713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surgical treatment of 402 consecutive cases for hilar cholangiocarcinoma: Chinese single center experience].
    Zhou NX; Huang ZQ; Zhang WZ; Huang XQ; Wang J; Liu R; Ji WB; Xiao M; Meng XF
    Zhonghua Wai Ke Za Zhi; 2006 Dec; 44(23):1599-603. PubMed ID: 17359686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.